Skip to content

Steven Bloembergen, PhD

Chairman and CEO at GreenMark Biomedical.

Earliest Form D on file: Apr 2026

Filed Apr 14, 2026

GreenMark Biomedical

Starch nanoparticle rinse that reveals early tooth decay

Biotech, East Lansing MI

Signed as Chairman and CEO

$0

sold of $5M offered

Form D

LinkedIn

Network

At GreenMark Biomedical

2 people